Report Indicates Brand-Name Drug Prices Increased 9.1% In 2009.

The Wall Street Journal (4/20, Mathews, subscription required) reports that drugmakers increased prices for brand-name drugs by 9.1% in 2009, according to a report by Express Scripts Inc. Meanwhile, specialty drug prices jumped 11.5%, compared to 9.4% in 2008. While some drugmakers claim their pricing was not affected by the healthcare overhaul, analysts suggest the increases were tied to higher Medicaid rebates among other expenses drugmakers would have under the new law.